Periodic Reporting for period 1 - AMNIOGEL (Extracellular matrix derived products from human placenta to engineer bone microtissues for in vitro disease models.)

The aim of ‘AMNIOGEL’ is the development of human extracellular matrix (ECM) based materials, as radically innovative, highly versatile human-derived platforms for 3D cell culture, microtissue development and disease models establishment. In particular, we will develop 3D...